Diterpenes: A therapeutic promise for cardiovascular diseases

Recent Patents on Cardiovascular Drug Discovery

Volumn 3, Issue 1, 2008, Pages 1-8

  Tirapelli, Carlos R ^a   Ambrosio, Sergio R ^b   da Costa, Fernando B ^a   de Oliveira, Ana M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DE FRANCA   (Brazil)

Author keywords

Calcium; Diterpenes; Hypertension; Kauranes; Pimaranes; Smooth muscle

Indexed keywords

14 DEOXYANDROGRAPHOLIDE; ADENYLATE CYCLASE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CARDIOVASCULAR AGENT; DILTIAZEM; DITERPENE; DITERPENOID; ELEGANOLONE; FORSKOLIN; GRAYANOTOXIN I; KAURENE DERIVATIVE; KAURENOIC ACID; MARRUBENOL; NATURAL PRODUCT; NIFEDIPINE; ORTHOPSINOL A; PIMARADIENOIC ACID; PIMARANE DERIVATIVE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT; VERAPAMIL; VIGUIERA ARENARIA EXTRACT; VIGUIERA ROBUSTA EXTRACT;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; HYPERTENSION; INHIBITION KINETICS; MEAN ARTERIAL PRESSURE; MEDICINAL PLANT; NONHUMAN; PHARMACOLOGICAL BLOCKING; PLANT ROOT; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; VASODILATATION; VIGUIERA ROBUSTA;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DITERPENES; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PATENTS AS TOPIC; PLANTS, MEDICINAL;

EID: 38949096124     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489008783331689     Document Type: Article

References (70)

1. Fabricant DS, Famsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Persp 2001; 109(1):69-75.
2. Soejarto DD. Biodiversity prospecting and benefit-sharing: perspective from the field. J Ethnopharmacol 1996; 51: 1-15.
3. Rates SMK. Plants as source of drugs. Toxicon 2001; 39: 603-613.
4. Vuorela P, Leinonen M, Saikku P, et al. Natural products in the process of finding new drug candidates. Curr Med Chem 2004; 11 (11):1375-1389.
5. Srivastava V, Negi AS, Kumar JK, Gupta MM, Khanuja PS. Plant-based anticancer molecules. A chemical and biological profile of some important leads. Bioorg Med Chem 2005; 13(11): 5892-5908.
6. El Bardai S, Morel N, Wibo M, et al. The vasorelaxant activity of Marrubenol and Marrubiin from Marrubium vulgare. Planta Med 2003; 69: 75-77.
7. El Bardai S, Wibo M, Hamaide MC, Lyoussi B, Quentin-Leclercq J, Morel N. Characterisation of marrubenol, a diterpene extracted from Marrubium vulgare, as an L-type calcium channel blocker. Br J Pharmacol 2003; 140: 1211-1216.
8. Tirapelli CR, Ambrosio SR, Da Costa FB, Coutinho ST, De Oliveira DC, De Oliveira AM. a. Analysis of the mechanisms underlying the vasorelaxant action of kaurenoic acid in the isolated rat aorta. Eur J Pharmacol 2004; 25 (492): 233-241.
9. Tirapelli CR, Ambrosio SR, Da Costa FB, De Oliveira AM. Evidence for the mechanisms underlying the effects of pimaradienoic acid isolated from the roots of Viguiera arenaria on rat aorta. Pharmacology 2004; 70: 31-38.
10. Silva RM, Oliveira FA, Cunha KMA, et al. Cardiovascular effects of trans-dehydrocrotonin, a diterpene from Croton Cajucata in rats. Vasc Pharmacol 2005; 43(1): 11-18.
11. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci 2005; 78(5):431-441.
12. Dewick PM, Ed, medicinal natural products: a biosynthetic approach.Chichester, John Wiley & Sons. 2004
13. Hanson JR. Diterpenoids. Nat Prod Reports 2003; 20: 70-78.
14. Hanson JR. Diterpenoids. Nat Prod Reports 2004; 21: 785-793.
15. Hanson JR. Diterpenoids. Nat Prod Reports 2006; 23: 875-885.
16. García PA, De Oliveira AB, Batista R. Occurrence, biological activities and synthesis of kaurane diterpenes and their glycosides. Molecules 2007; 12: 455-483.
17. Vogalis F, Publicover NG, Hume JR, Sanders KM. Relationship between calcium current and cytosolic calcium in canine gastric smooth muscle cells. Am J Physiol 1991; 260:C10-12.
18. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1996; 38:321-416.
19. Sato K, Ozaki H, Karaki H. Changes in cytosolic calcium level in vascular smooth muscle strip, measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 1988; 246:294-300.
20. 2+ and contraction in norepinephrine-stimulated vascular smooth muscle. Jpn J Pharmacol 1991; 55:35-42.
21. El Bardai S, Lyoussi B, Wibo M, Morel N. Pharmacological evidence of hypotensive activity of Marrubium vulgare and Foeniculum vulgare in spontaneously hypertensive rat. Clin Exp Hypertens 2001; 23: 329-343.
22. Fulke JWB, Henderson MS, McCrindle R. Reactions of the diterpene marrubiin and its congeners. J Chem Soc 1968; 7: 807-810.
23. Wibo M, Deroth L, Godfraind T. Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies. Circ Res 1988; 62: 91-96.
24. Baccelli C, Block S, Van Holle B, et al. Diterpenes isolated from Croton zambesicus inhibit KCl-induced contraction. Planta Med 2005; 71(11):1036-1039.
25. Baccelli C, Navarro I, Block S, Abad A, Morel N, Quetin-Leclercq J. Vasorelaxant activity of diterpenes from Croton zambesicus and synthetic trachylobanes and their structure-activity relationships. J Nat Prod 2007; 70(6): 910-917.
26. Lozoya X, Enriquez RG, Bejar E, et al. The zoaplate. The effect of kauradienoic acid upon uterine contractility. Contraception 1983; 258: 297-301.
27. Bejar E, Lozoya X, Enriquez RG, Escobar L. Comparative effect of zoapatle (Montanoa tomentosa) products and of verapamil on the in vitro uterine contractility of rat. Arch Invest Méd 1984; 15: 223-235.
28. Campos-Bedolla P, Campos MG, Valencia-Sanches A, Ponce-Monter H. Effect of kauranes from Montanua spp. on rat uterus. Phytother Res 1997; 11: 11-16.
29. Da Costa FB, Ambrosio SR, Tirapelli CR, De Oliveira AM. Inhibitory effect of kaurenoic acid isolated from Viguiera Robusta (Asteraceae) on the phenylephrine and KCl spasmogenic effect in rat carotid muscle. Phytomedicine 2000; 7: 77.
30. Tirapelli CR, Ambrosio SR, Da Costa FB, De Oliveira AM. Inhibitory action of kaurenoic acid from Viguiera robusta (Asteraceae) on phenylephrine-induced rat carotid contraction. Fitoterapia 2002; 73: 56-62.
31. Tirapelli CR, Ambrosio SR, Do Costa FB, De Oliveira AM. Antispasmodic and relaxant actions of kaurenoic acid (KA) isolated from Viguiera robusta on rat carotid. Braz J Pharm Sci 2003; 39: 148.
32. Hudgins A, Weiss G. Effects of calcium removal upon vascular smooth muscle contraction induced by noripenephrine, histamine and potassium. J Pharmacol Exp Ther 1968; 159: 91-97.
33. 2+ channels in rat aortic smooth muscle. Br J Anesth 1999, 81: 578-583.
34. De Alencar-Cunha KM, Paiva LAF, Santos FA, Gramosa NV, Silveira ER, Rao VSN. Smooth muscle relaxant effect of kaurenoic acid, a diterpene from Copaifiera langsdorfii on rat uterus in vitro. Phytother Res 2003; 17: 320-324.
35. + channels in arterial smooth muscle. Am J Physiol 1995; 268: 799-822.
36. Kuriyama H, Kitamura K, Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev 1995; 47: 387-573.
37. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
38. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function an communication. Biochem Pharmacol 1989; 38: 1709-1715.
39. Schini VB, Vanhoutte PM. L-Arginine evokes both endothelium-dependent and independent relaxations in L-arginine-depleted aortas of the rat. Circ Res 1991; 68: 209-216.
40. Sahney S. A review of calcium channel antagonists in the treatment of pediatric hypertension. Pediatr Drugs 2006; 8(6):357-373.
41. Triggle DJ. L-Type calcium channels. Curr Pharm Des 2006; 12(4): 443-457.
42. Enriquez RG, Bejar E, Lozoya X. Role of kauradienoic acid and its methyl ester on the effect elicited by Montanoa tomentosa upon the uterine contractility in vitro. Arch Invest Méd 1984; 15: 236-238.
43. Muller S, Tirapelli CR, De Oliveira AM, Murillo R, Castro V, Merfort I. Studies of ent-kaurane diterpenes from Oyedaea verbesinoides for their inhibitory activity on vascular smooth muscle contraction. Phytochemistry 2003; 63: 391-396.
44. Ambrosio SR, Tirapelli CR, Da Costa FB, Coutinho ST, De Oliveira DC, De Oliveira AM. Role of the carboxylic group in the antispasmodic and vasorelaxant action displayed by kaurenoic acid. J Pharm Pharmacol 2004; 56(11): 1407-1413.
45. Riswan S, Sangat HM 1991. "Jamu as a Javanese Traditional Medicine in Indonesia". The bioresources-diversity, ethnobiology development and-sustainability international centenary conference, Sydney. In Ohashi K, Bohgaki T, Matsubara T, Shibuya H. Chemical structures of two new migrated pimarime-type diterpenes, neoorthosiphols A and B, and suppressive effects on rat thoracic aorta of chemical constituents isolated from the leaves of Orthosiphon aristatus (Lamiaceae). Chem Pharm Bull 2000; 48: 433-435.
46. Ohashi K, Bohgaki T, Matsubara T, Shibuya H. Chemical structures of two new migrated pimarane-type diterpenes, neoorthosiphols A and B, and suppressive effects on rat thoracic, aorta of chemical constituents isolated from the leaves of Orthosiphon aristatus (Lamiaceae). Chem Pharm Bull 2000; 48: 433-435.
47. Ambrosio SR, Tirapelli CR, Bonaventura D, De Oliveira AM, Da Costa FB. Pimarane diterpene from Viguiera arenaria (Asteraceae) inhibit rat carotid contraction. Fitoterapia 2002; 73: 484-489.
48. Tirapelli CR, Ambrosio SR, Da Costa FB, Coutinho ST, De Oliveira DCR, De Oliveira AM. Pharmacological comparison of the vasorelaxant action displayed by kaurenoic acid and pimaradienoic acid. J Pharm Pharmacol 2005; 57(8): 997-1004.
49. Alvarenga SAV, Gastmans JP, Rodrigues GV, Moreno PRH, Emerenciano VP. A computer-assisted approach for chemotaxomic studies - diterpenes in Lamiaceae. Phytochemistry 2001; 56: 583-595.
50. Cox RE, Yamamoto S, Otto A, Simoneit BRT. Oxygenated di- and tricyclic diterpenoids southern hemisphere, conifers. Biochem Syst Ecol 2007; 35: 342-362.
51. Mosaddik MA, Forster PI, Booth R, Waterman PG. Clerodane diterpenes from the stems of Casearia grewiifolia var. gelonioides (Flacourtiacaae/Salicaceae sesus lato). Biochem Syst Ecol 2007; 35: 631-633.
52. Brinker AM, Ma J, Lipsky PE. Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Ceastraceae). Phytochemistry 2007; 68: 732-766.
53. Seaman F., Bohlmann F, Zdero C, Mabry TJ, Eds, diterpenes of flowering plants - Compositae (Asteraceae). New York, Springer-Verlag. 1990.
54. Monezes FS, Kaplan MAC. Ocorrencia de diterpeniods na familial Lamlaceae. Rev Bras Farm 1993; 74(2):45-46.
55. Vaccarini CE, Palacios SM, Meragelman KM, Sosa VE. Phytogrowth-inbibitory activities of a clerodane from Viguiera tucumanensis. Phytochemistry 1999; 50: 227-230.
56. Meragelman KM, Espinar LA, Sosa VE, Uriburu ML, De La Fuente JR. Terpenoid constituents of Viguiera tucumanensis. Phyotchemistry 1996; 41: 499-502.
57. Da Costa FB, Vichnewski W, Herz W. Constituents of Viguiera aspillioides and V. robusta. Biochem Syst Ecol 1996; 24: 585-587.
58. Tamayo-Castillo G, Jakupovic J, Bohlmann F, King RM, Boldt PE. Germacranolides and diterpenes from Vigurera species. Rev Lat Am Quim 1990; 21: 67-69.
59. Domingues XA, Ellmauerer E, Sanches HV, Franco OR, Verde JS. Viguiera superaxillare ("Romerillo"), a further source of a cycloartenone derivate. Rev Lat Am Quim 1988; 19:144.
60. Romo de Vivar, Delgado G. Los metabolitos secundarios de Viguiera (Compositae, Heliantheae). Quimica e implicaciones quimiotaxonômicas. Bol Soc Chil Quim 1985; 30: 79-100.
61. Bohlmann F. Chemistry of the Heliantheae (Compositae). In Mabry TJ, Wagenitz G. Research Advances in the Compositae. P1 Syst Evol 1990; 4: 67-75.
62. Ambrosio SR, Schorr K, Da Costa FB. Terpenoids of Viguiera arenaria (Asteraccae). Biochem. Syst Ecol 2004; 32:121-224.
63. Da Costa FB, Schorr K, Arakawa NS, Schilling EE, Spring O. Intraspecific variation in the chemistry of glandular trichomes of two Brazilian Viguiera species (Heliantheae; Asteraceae). J Braz Chem Soc 2001; 12:403-407.
64. Ambrosio SR, Tirapelli CR, Da Costa FB, De Oliveira AM. Kaurane and pimarane-type diterpenes from the Viguiera species inhibity vascular smooth muscle contractility. Life Sci 2006; 79: 925-933.
65. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006; 27: 1-93.
66. Houghton PJ. Use of small scale bioassays in the discovery of novei drugs from natural sources. Phytother Res 2000; 14: 419-423.
67. Senin, P., Setnikar, I., Rovati, L.A.: WO07113748 (2007).
68. Miller, D.L., Katz, D.: WO07098205 (2007). 69 Wang, Y., Zidichouski J.: WO07090289 (2007).
69. Wang, Y., Zidichouski, J.: WO07090289 (2007)
70. Chajut, A., Pinner, E.: WO07029249 (2007).